Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Noraker is a French medical technology company specializing in the design and manufacture of innovative bioactive glass implants for bone and dental regeneration. Founded in 2005 and headquartered in Lyon, the company utilizes its proprietary 45S5 bioactive glass platform to develop products that are both osteoconductive and osteostimulative. Their portfolio includes bone graft substitutes, dental fillers, and interference screws used in sports medicine and orthopedic surgery. Noraker's products are designed to be resorbed and replaced by natural bone over time, providing a scaffold for healing. The company is currently in the commercial stage, distributing its solutions globally to improve patient outcomes in regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Noraker.